BMO Capital Downgraded Exelixis (EXEL:NASDAQ) to Market Perform


Silver bull and bear in the newspaper

peterschreiber.media

  • BMO Capital Markets downgraded Exelixis (NASDAQ:Excel) to outperform the market as it sees limited upside for the stock in 2025.
  • The investment firm said it sees a balanced risk/reward for the upcoming reading of zanzalintinib in colorectal cancer, or



Source link

Leave a Reply

Your email address will not be published. Required fields are marked *